DISEASE INDICATIONS: Amyotrophic Lateral Sclerosis (ALS)
MANUFACTURER: Glentek
USAGE: Oral
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Therapeutic Goods Administration (TGA)
Medicines & Healthcare products Regulatory Agency (MHRA)
The Medicines Evaluation Board (MEB)
Glentek is a medication belonging to the class of drugs known as glutamate inhibitors. It is primarily used in the treatment of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.
